This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Breast cancer-specific survival in 6, 768 patients with lymph nodepositive (LN+) hormone receptor-positive (HR+) invasive breast cancer (BC) and 21-gene Recurrence Score® (RS) results in the SEER registries. (March 2017)
Record Type:
Journal Article
Title:
Breast cancer-specific survival in 6, 768 patients with lymph nodepositive (LN+) hormone receptor-positive (HR+) invasive breast cancer (BC) and 21-gene Recurrence Score® (RS) results in the SEER registries. (March 2017)
Main Title:
Breast cancer-specific survival in 6, 768 patients with lymph nodepositive (LN+) hormone receptor-positive (HR+) invasive breast cancer (BC) and 21-gene Recurrence Score® (RS) results in the SEER registries